GLPG: Galapagos Book Value of Business

Public company logo of Galapagos (GLPG)

Galapagos NV is developing a diversified portfolio through asset acquisitions and partnerships with biotech startups. The price trend shown below illustrates the dynamics of these processes, with the indicator standing at 3.79. Galapagos NV relies on payments from global corporations and future royalties from the commercialization of CAR-T therapy. Simultaneously, the holding company adheres to medical regulations while reducing energy costs at its European laboratories.

GLPG Galapagos Corp Book Capitalization (07/04/2022 - 05/08/2026)

Metric breakdowns and analytics for Galapagos (GLPG)

- price and consensus price forecast:
Quote Chart Galapagos Corp|GLPG - Analyst Consensus Forecast
- market capitalization data:
Market Capitalization Galapagos N.V.|GLPG - Total Company Value
- book capitalization data:
Share Book Value Galapagos|GLPG - Book Capitalization|Market Value to Book Value glpg.com|GLPG - Company Total Assets
- debt and liquidity data:
Total Debt to Capital Galapagos NV|GLPG - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital Galapagos N.V.|GLPG - Company Debts|Debt to Book Value Galapagos N.V.|GLPG - Company Long-Term Debts|Company Short-Term Debts Galapagos
Fundamental valuation:GLPG - Galapagos Corp
Flagship merchandise of Galapagos N.V.

Book value represents the difference between total assets and all liabilities, allowing an investor to assess the actual value of equity without market noise. By analyzing the book value trend of net assets, one can see how license royalties and partnerships with pharma behemoths within the Inertia platform ensure a steady increase in resources for Galapagos NV (GLPG).

Competitor analysis for Galapagos NV

HLN - Net Asset Value|Book Capitalization KVUE (Kenvue Inc.)|VRNA (veronapharma.com) - Book Value of Business|Company Book Value Jyong Biotech MENS|Net Asset Value Ligand Pharmaceuticals Incorporated|Amneal Pharmaceuticals Inc (AMRX) - Book Capitalization|Accounting Value of Company Perrigo Corp (PRGO)|Book Capitalization ALVO (Alvotech)|liquidia.com - Book Capitalization|Company Book Value ANI Pharmaceuticals, Inc. (ANIP)|MNKD: Accounting Value of Company|AMPH (Amphastar) - Company Book Value|Pacira Corp (PCRX) - Company Net Assets|SPRY (ARS Pharmaceuticals) - Book Capitalization|Book Capitalization theravance.com (TBPH)|Aquestive Therapeutics, Inc. (AQST) - Company Net Assets|Accounting Value of Company SCPH (scpharmaceuticals.com)|TECX: Company Book Value|TNXP - Total Stockholders' Equity|Company Net Assets SXT China SXTC|EPRX - Total Net Assets|Book Capitalization BioHarvest Sciences Inc. BHST|Invizyne Technologies (EXOZ) - Accounting Value of Company|Book Capitalization ORMP (Oramed)|Total Stockholders' Equity ENTX|MindWalk Holdings (HYFT) - Company Book Value|Accounting Value of Company abvcpharma.com (ABVC)|CPIX (Cumberland Pharmaceuticals Inc.) - Book Capitalization|Book Value of Business Quantum BioPharma Ltd. QNTM|FibroGen Corp - Book Capitalization|TELO: Book Capitalization|ranitherapeutics.com (RANI) - Company Book Value|Synergy CHC (SNYR) - Company Book Value|RLYB (Rallybio Corp) - Book Capitalization|Book Capitalization LEXX|PULM - Company Book Value|Net Asset Value ftzy.com.cn (PTHL)|Book Capitalization APM (Aptorum Group)|Book Capitalization lyratherapeutics.com LYRA|Book Capitalization IBO|TNFA: Book Value of Business|Company Book Value YCBD|PRFX (PainReform Corp) - Total Stockholders' Equity|CYTO: Company Book Value|Book Valuation of Business lipella.com (LIPO)|OptiNose (OPTN) - Company Net Assets|Accounting Value of Company PIRS (Pieris Pharmaceuticals Inc)|PROC - Company Book Value|PTPI - Accounting Capitalization|QLI - Company Net Assets|SLRN - Company Book Value|Book Capitalization TFFP (TFF Pharmaceuticals, Inc.)